Inhibiting SPINK4 might potentially reduce CRC cell proliferation and make tumor cells more susceptible to ferroptosis-inducing drugs, enhancing therapy results for CRC patients (Figure 3) [52,54,55]. Here, SPINK4 is linked to colorectal carcinoma.